HealthMarketWatch
Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars
The Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weight-loss drugs.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
The Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weight-loss drugs.
Join the argument
House rules →Comments load as you scroll.